This study will compare and assess the prevalence of osteopenia and vitamin D deficiency as well…
Category: Studies
A long-term follow-up study for tuberculosis patients
This is a long-term cohort study of tuberculosis (TB) patients. This database will capture diagnosis of…
A phase 2, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of TMC278 in antiretroviral naive HIV-1 infected adolescents aged 12 to < 18 years
This is a Phase II, open-label (all people involved know the identity of the assigned drug)…
RTV GPO tablet study
This is pharmacokinetics, boosting efficacy and safety of GP-ritonavir tablets in HIV patients currently stable on…
Early ART to Limit Infection and Establishment of Reservoir (EARLIER)
This study will assess the effect of antiretroviral treatment initiated during acute HIV-1 infection on measures…
A phase 2/3, multicenter, open-label, multicohort, two-part study evaluating Pharmacokinetics (PK), safety, and efficacy of cobicistat-boosted Atazanavir (ATV/co) or cobicistat-boosted Darunavir (DRV/co), administered with Background Regimen (BR) in HIV-1 infected, treatment-experienced, virologically suppressed pediatric subjects
This study will evaluate the steady-state pharmacokinetics (PK) and confirm the dose of cobicistat-boosted atazanavir (ATV/co)…
A randomized, double-blind phase 3b study to evaluate the safety and efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate versus Ritonavir-boosted Atazanavir plus Emtricitabine/Tenofovir disoproxil fumarate in HIV-1 infected, antiretroviral treatment-naïve women
Randomized, double-blinded, multicenter, active-controlled study to evaluate the safety and efficacy of a regimen containing elvitegravir/cobicistat/emtricitabine/tenofovir…
A phase 3 clinical trial of ultra-course Rifapentine/Isoniazid for the prevention of active tuberculosis in HIV-infected individuals with latent tuberculosis infection
This study will compare rifapentine plus isoniazid daily for 4 weeks to a standard regimen of…
PTB Pascolizumab
This is a randomized, double-blind, placebo-controlled, proof of concept clinical trial to assess the safety and…
A phase 2/3 multicenter, open-label, multicohort, two-part study evaluating the pharmacokinetics (PK), safety, and antiviral activity of Elvitegravir (EVG) administered with a background regimen (BR) containing a Ritonavir-boosted protease inhibitor (PI/r) in HIV-1 infected, antiretroviral treatment-experienced pediatric subjects
This is an open-label, multicenter, multicohort, two-part study to confirm the dose and evaluate the safety…
HIV reservoir in early-treated children
This is a cross-sectional study of clinical data and blood sample collection for HIV reservoir and…
The latent HIV reservoir in early treated Thai children
This is a prospective observational study that will characterize the HIV reservoir size and replication, and…
Natural history of hepatitis C infection, clinical significances, prognostic factors and treatment outcome/toxicity among Thai HIV-infected patients with chronic hepatitis
This is a cohort study that will use questionnaires and collect specimens/samples to assess the natural…
Evaluating pharmacokinetics interactions with vaginal ring contraceptive and ART
This study will look at a method of hormonal birth control, called the NuvaRing, and specific…
A phase 2 multiple ascending dose proof of concept study
This is a phase IIa, randomized, open-label, ascending, sequential dose group, multiple dose study of the…
